HLA associations with inclusion body myositis

Area of Science:

• Immunogenetics
• Rheumatology
• Neuromuscular Disorders

Background:

• Inclusion body myositis (IBM) is a progressive muscle disease characterized by weakness and resistance to steroids.
• Histological findings include rimmed vacuoles, inclusions, and CD8+ T cell infiltrates, suggesting autoimmune mechanisms.
• The immunogenic features and genetic predisposition of IBM remain poorly understood.

Purpose of the Study:

• To investigate the immunogenic features and genetic predisposition in patients with Inclusion body myositis.
• To identify specific human leukocyte antigen (HLA) and complement gene associations with IBM.

Main Methods:

• Human leukocyte antigen (HLA) class I and DR antigens were typed using serological and oligonucleotide methods.
• Complement components C4 and properdin factor B (Bf) were analyzed by immunofixation.
• Restriction fragment length polymorphisms (RFLP) in the class III region were assessed using cDNA probes for C4 and 21-hydroxylase (CYP21).

Main Results:

• IBM patients showed a high prevalence of DR3 (92%), DR52 (100%), and HLA B8 (75%).
• A significant association was observed with the extended haplotype B8/C4A*Q0/C4B1/BfS/DR3/DR52, common in autoimmune diseases.
• Two patients carried the B18/C4A3/C4BW*0/BfF1/DR3 haplotype, linked to insulin-dependent diabetes mellitus.

Conclusions:

• The study provides evidence for a genetic predisposition to Inclusion body myositis.
• The identified HLA and complement associations support an autoimmune etiology for IBM.
• These findings may contribute to understanding IBM pathogenesis and developing targeted therapies.